Immunis Chairman Dr. Hans Keirstead to Speak at the Ending Age-Related Diseases Summit

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a private biotechnology company pioneering cellular secretome therapies for age and disease-related immune decline, is excited to announce that its Chairman, Dr. Hans Keirstead, will be a panelist at Lifespan.io’s Ending Age-Related Diseases Summit. The summit in New York brings together the world’s foremost experts…
Click here to view original post